drugset / Trial / NCT02791815
Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects
RandomizedCrossoverOpen-label
Summary
The primary purpose of this study is to evaluate the effect of repeated doses of selexipag on the pharmacokinetics of a single oral dose of midazolam (i.e., how long and how much midazolam is present in the blood)
Timeline
- Start
- 2016-07
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | 7.5 mg | Oral |
| Subject | Selexipag | Small molecule | 1600 ug | Oral |
Indications
No indication recorded.